课题基金 / 基金详情

Lipid droplets and the regulation of ferroptosis

Lipid droplets and the regulation of ferroptosis
脂滴与铁死亡的调节
批准号:
10248497
负责人:
Siti Nur Sarah Morris
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-09 至 2021-09-25

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目总结 铁下垂是一种受调控的细胞死亡形式,它会在铁中产生活性氧物种(ROS)。 依附时尚。最重要的RO是过氧化脂质,它会在血浆中自我繁殖。 并导致氧化损伤的脂类堆积。这些过氧化脂质会导致 细胞膜的完整性,细胞和亚细胞内容物的泄漏,最终导致细胞死亡。主要防护措施 抗铁下垂的机制依赖于谷胱甘肽依赖的过氧化物酶(Gpx4);这种酶将 脂质过氧化为脂醇,从而阻止细胞死亡。这一保护途径中的缺陷一直是 与许多神经退行性疾病的病因学有关。相反,废除Gpx4有 使耐药癌细胞对化疗药物敏感。不幸的是,我们对 铁下垂的潜在机制仍然有限,但铁下垂调节的一种可能性可能在 酰辅酶A合成酶长链4(ACSL4)。这种酶将游离的长链脂肪酸转化为 脂肪酰辅酶A酯,磷脂的组成部分,注定要传播铁下垂。 在体内和体外的多种模型中,ACSL4基因的敲除已经被证明可以延缓铁下垂的发生。 有趣的是,ACSL4基因可以通过选择性剪接产生两种同工酶;这两种同工酶在 长度和定位,其中长型共定位于脂滴(LDS)和短型共定位- 定位于质膜(PM)。我们假设,这种差异局域化调制了铁上链。 作为对LDS的过氧化脂质的封存,敏感性可防止由铁性下垂引起的死亡。为了 为了解决这个问题,将建立内源性ACSL4已被消除和取代的细胞系 ACSL4的两种主要剪接形式具有不同的表达结构。此外,这些拼接形式将 以不同的亚细胞定位为目标,以调查这些隔室在执行 铁性细胞死亡。此外,由于ACSL4是脂类代谢的组成部分,我们将研究 通过拉曼光谱分析脂肪酸组成,并通过脂类组学表征脂肪酸通量。这 该项目阐述了调节铁下垂的一个重要步骤,即如何隔离受损的 远离临界膜区域的脂质可能会对铁链细胞的死亡产生负面影响。这种酶可以 管理这种隔离,ACSL4,因此具有巨大的药理潜力,不仅作为新药的靶点 抗癌药物,也可用于与年龄相关的神经疾病。
英文摘要
PROJECT SUMMARY Ferroptosis is a form of regulated cell death that generates reactive oxygen species (ROS) in an iron- dependent fashion. The most important of the ROS are lipid peroxides, which self-propogate along the plasma membrane and result in the accumulation of oxidatively damaged lipids. These lipid peroxides lead to a loss of membrane integrity, leakage of cellular and subcellular content and, ultimately, cell death. The main protective mechanism against ferroptosis relies on a gluathione-dependent peroxidase (GPX4); this enzyme converts lipid peroxides to lipid alcohols, thus blocking cell death. Defects in this protective pathway have been implicated in the etiology of a number of neurodegenerative disorders. Conversely, abrogation of GPX4 has sensitized drug-resistant cancer cells to chemotherapeutics. Unfortunately, our understanding of the mechanisms underlying ferroptosis remain limited, but one possibility of ferroptotic regulation may be found in the enzyme acyl-CoA synthetase long-chain 4 (ACSL4). This enzyme converts free long-chain fatty acids into fatty acyl-CoA esters, the building blocks of the phospholipids that are fated to propagate ferroptosis. Knockout of ACSL4 has been shown to stave off ferroptosis in multiple in vivo and in vitro models. Interestingly, the ACSL4 gene can produce two isoenzymes via alternative splicing; these isoforms differ in length and in localization, where the long form co-localizes to lipid droplets (LDs) and the short form co- localizes to the plasma membrane (PM). We hypothesize that this differential localization modulates ferroptotic sensitivity as the sequestration of lipid peroxides to the LDs may prevent death by ferroptosis. In order to address this question, cell lines will be created in which endogenous ACSL4 has been eliminated and replaced with a different expression construct for the two major splice forms of ACSL4. Moreover, these splice forms will be targeted to various subcellular localizations to investigate the role of these compartments in the execution of ferroptotic cell death. Additionally, since ACSL4 is integral to lipid metabolism, we will investigate the composition of fatty acids via Raman spectroscopy and characterize fatty acid flux through lipidomics. This project addresses an important step in the regulation of ferroptosis, namely how sequestration of damaged lipids away from critical membrane regions may negatively affect ferroptotic cell death. The enzyme that governs this sequestration, ACSL4, thus has great pharmacologic potential, not only as a drug target for novel anti-cancer drugs, but also in age-related neurological diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金